Company is listed on Bombay Stock Exchange and the National Stock Exchange in India. The Company was established in 1995 and has two divisions:
Agri Bio Sciences division:
The product range includes Herbal-based Nutraceuticals for management of lifestyle diseases.
Company has its floriculture operations cultivating, processing and exporting cut flower roses. The company over the past 15 years has grown and expanded its agriculture operations into floriculture, nursery, contract farming and procurement and trading of agri-commodities. The Company also diversified into manufacturing and outsourcing of herbal extracts, formulations and dietary supplements for life style disease management, which include Bio-Nutraceuticals, Nutritional products, Fortified Proteins and Natural Oxidants, Probiotics and Prebiotic, Alpha- Omega Fatty Acids.
Biologics and Life Sciences Division:
Established in 2009, the state of the art multi-product USFDA compliant Bio-Pharma unit spreads over 3.86 acres of land. This plant shall utilize cell fusion techniques, hybidomas recombinant DNA technology, protein engineering, bacterial expressions and structure based molecular design which is part of modern Biotechnology.
The product range shall include Biosimilar products, such as Vaccines, synthetic therapeutic peptides, Probiotics, Proteins, different parenteral formulations (anticancer, antimalarial, antibiotics, antiviral, anemia, etc.) and dietary supplements.
This division requires this round of funding to start operations.
Company has completed its Phase 1 expansion (spending $9mn) and additionally has spent $3mn for the required infrastructure of Phase 2 for its Biotech division.
Due to this aggressive expansion and overleveraging, recently the Bank put the Company operations on hold due to its inability to service the outstanding loans. Thus the need for injecting additional capital.
Company requires additional $13.5mn to service part of its loans and complete its Phase 2 expansion. Funding can be in the form of debt or preferred shares.
Financials: in USD mn
Years Revenues EBITDA
2020 77 29
2019 51 18
2018 33 7
2017 20 4
2016 17 2
2015 20 3.5
2014 19 3.5
2013 20 3
Asking Price Between $10,000,000 and $15,000,000
Sales Between $10,000,000 and $25,000,000
Profit Between $2,500,000 and $5,000,000
You May Also Like
Ayurvedic Pharma & Cosmetics Company at Kolkata #452753 posted Aug 30, 2016
- Between $100,000 and $500,000
40 Years old Pharmaceutical Private Limited Company with modern manufacturing facilities complying with the norms of GMP, providing Proprietary Ayurvedic Medicines, private label service, contract manufacturing facility for Ayurvedic Medicines, Veterinary Medicines, food products, Nutritional, Herbal...
Oncology Generics and Specialty Drugs Maker #450698 posted Jul 31, 2016
- Between $2,500,000 and $5,000,000
ALPHA is a knowledge based, specialty pharmaceutical company. It aims at developing differentiated products across a wide spectrum of therapeutic areas, by applying underlying rigorous scientific principles. ALPHA serves the pharmaceutical needs of diverse markets worldwide through strong in-house...
Profitable Manufacturing Business India #362726 posted Aug 10, 2014
- Between $15,000,000 and $20,000,000
Profitable Multispecialty Bandages, Dressings, Transdermal Patch, Drugs, Neutraceuticals, Antiseptic Liquid, Creams, Powder and Cosmetics and Ayurveda Products Manufacturer available with 30 years Brand, Exporting Worldwide cash sales, including Own Freehold Land & GMP Buildings(Multilocation), EU...
Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.